ERBB4 (HER4) is a member of the ERBB family of receptor tyrosine kinases, a family that
includes the epidermal growth factor receptor (EGFR/ERBB1/HER1), ERBB2 (Neu/HER2), and …

Epidermal growth factor (EGF) family peptides are ligands for the EGF receptor (EGFR).
Here, we elucidate functional differences among EGFR ligands and mechanisms underlying …

Importance The diagnostic properties of a graded provocation challenge (PC) among
children presenting with a rash in the course of amoxicillin treatment are currently unknown. …

Ecotropic viral integration site 1 (Evi1) was discovered in 1988 as a common site of ecotropic
viral integration resulting in myeloid malignancies in mice. EVI1 is an oncogenic zinc-finger …

The PROTAC (proteolysis-targeting chimera) ARV-825 recruits bromodomain and extraterminal
(BET) proteins to the E3 ubiquitin ligase cereblon, leading to degradation of BET proteins…

Abstract Treatment with Menin inhibitor (MI) disrupts the interaction between Menin and
MLL1 or MLL1-fusion protein (FP), inhibits HOXA9/MEIS1, induces differentiation and loss of …

RUNX1 transcription factor regulates normal and malignant hematopoiesis. Somatic or
germline mutant RUNX1 (mtRUNX1) is associated with poorer outcome in acute myeloid …

The majority of RUNX1 mutations in acute myeloid leukemia (AML) are missense or deletion-truncation
and behave as loss-of-function mutations. Following standard therapy, AML …

Myeloproliferative neoplasms with myelofibrosis (MPN-MF) demonstrate constitutive activation
of Janus kinase/signal transducer and activator of transcription (JAK/STAT) signaling that …

In MLL1-rearranged AML (MLL1-r), the MLL1 fusion protein (MLLFP) causes dysregulated
expression of HOXA9, MEIS1, PBX3, MEF2C and CDK6 [1, 2]. HOXA9 and its co-factor MEIS1 …